Immunoglobulin G4 연관 질환 = Immunoglobulin G4-Related Disease

다국어 초록 (Multilingual Abstract)

Immunoglobulin G4-related disease (IgG4-RD) is an emerging immune-mediated fibro-inflammatory disorder which can involve any organ. The main characteristics of IgG4-RD are increased serum IgG4 concentration, abundant IgG4+ plasma cells in affected tissues, and painless swollen organs often without general symptoms. Typical pathology features of IgG4-RD are lymphoplasmacytic infiltration, dense storiform fibrosis, and obliterative pheblitis. The pathogenesis of IgG4-RD remains elusive, but involvement of excess production of type 2 T helper cells, regulatory T-cell cytokines, and B-cell activating factor in the development of IgG4-RD has been suggested. Diagnosis of IgG4-RD can be made on the basis of serological, imaging, particularly histopathological findings. Glucocorticoid is the first-line therapy for patients with multiple organ dysfunction and clinical symptoms. Drugs such as azathioprine, mycophenolate mofetil, methotrexate, and cyclophosphamide can be used as steroid-sparing agents. Rituximab is reported to be an effective therapy for treatment of IgG4-RD, even without concomitant glucocorticoid therapy. This review summarizes current concepts on pathophysiology, clinical manifestations, and treatment of IgG4-RD. (J Rheum Dis 2015;22:213-222)

참고문헌 (Reference)

1 Khosroshahi A., "Treatment approaches to IgG4-related systemic disease" 23 : 67-71, 2011

2 Watanabe T., "Toll-like receptor activation in basophils contributes to the development of IgG4-related disease" 48 : 247-253, 2013

3 Saeki T., "Thrombotic thrombocytopenic purpura in IgG4-related disease with severe deficiency of ADAMTS-13 activity and IgG4 autoantibody against ADAMTS-13" 63 : 1209-1212, 2011

4 Bando H., "The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature" 170 : 161-172, 2013

5 Deshpande V., "The pathology of IgG4-related disease : critical issues and challenges" 29 : 191-196, 2012

6 Brito-Zerón P., "The clinical spectrum of IgG4-related disease" 13 : 1203-1210, 2014

7 Saeki T., "The clinical course of patients with IgG4-related kidney disease" 84 : 826-833, 2013

8 Tanaka A., "Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease" 64 : 254-263, 2012

9 Deshpande V., "Subclassification of autoimmune pancreatitis : a histologic classification with clinical significance" 35 : 26-35, 2011

10 Ryu JH., "Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice" 2012 : 232960-, 2012

11 Boonstra K., "Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis" 59 : 1954-1963, 2014

12 Zen Y., "Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease" 29 : 212-218, 2012

13 Khosroshahi A., "Rethinking Ormond's disease : "idiopathic"retroperitoneal fibrosis in the era of IgG4-related disease" 92 : 82-91, 2013

14 Stone JH., "Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations" 64 : 3061-3067, 2012

15 Ryu JH., "Pulmonary manifestations of immunoglobulin G4-related sclerosing disease" 39 : 180-186, 2012

16 Cornell LD., "Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease" 31 : 1586-1597, 2007

17 Kawano M., "Proposal for diagnostic criteria for IgG4-related kidney disease" 15 : 615-626, 2011

18 Hicks J., "Progressive transformation of germinal centers : review of histopathologic and clinical features" 65 : 195-202, 2002

19 Uchida K., "Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009" 2012 : 358371-, 2012

20 Furukawa S., "Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease" 156 : 9-18, 2015

21 Wallace ZS., "Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations" 74 : 190-195, 2015

22 Kamisawa T., "Pancreatic cancer with a high serum IgG4 concentration" 12 : 6225-6228, 2006

23 Takagi D., "Otologic manifestations of immunoglobulin G4-related disease" 123 : 420-424, 2014

24 Wallace ZS., "Ophthalmic manifestations of IgG4-related disease : single-center experience and literature review" 43 : 806-817, 2014

25 Akiyama M, "Number of circulating T follicular helper 2 cells correlates with IgG4 and IL-4 levels and plasmablast numbers in IgG4-related disease" 2015

26 Shimizu Y., "Necessity of early intervention for IgG4-related disease : delayed treatment induces fibrosis progression" 52 : 679-683, 2013

27 Suzuki M., "Nasal manifestations of immunoglobulin G4-related disease" 123 : 829-834, 2013

28 Stone JH., "L45. Aortitis, retroperitoneal fibrosis, and IgG4-related disease" 42 : 622-625, 2013

29 Watanabe T., "Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domainlike receptors in enhanced IgG4 responses in autoimmune pancreatitis" 64 : 914-924, 2012

30 Della-Torre E., "Immunology of IgG4-related disease" 181 : 191-206, 2015

31 Kamisawa T., "IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy" 6 : 132-137, 2006

32 Castelein T., "IgG4-related periaortitis vs idiopathic periaortitis : is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis?" 54 : 1250-1256, 2015

33 Ferry JA., "IgG4-related lymphadenopathy and IgG4-related lymphoma : moving targets" 19 : 128-139, 2013

34 Sato Y., "IgG4-related lymphadenopathy" 2012 : 572539-, 2012

35 Zen Y., "IgG4-related lung and pleural disease : a clinicopathologic study of 21 cases" 33 : 1886-1893, 2009

36 Saeki T., "IgG4-related kidney disease" 85 : 251-257, 2014

37 Lu LX., "IgG4-related hypertrophic pachymeningitis : clinical features, diagnostic criteria, and treatment" 71 : 785-793, 2014

38 Uehara T., "IgG4-related disease-like fibrosis as an indicator of IgG4-related lymphadenopathy" 17 : 416-420, 2013

39 Khosroshahi A., "IgG4-related disease is not associated with antibody to the phospholipase A2 receptor" 2012 : 139409-, 2012

40 Stone JH., "IgG4-related disease : nomenclature, clinical features, and treatment" 29 : 177-190, 2012

41 Pieringer H., "IgG4-related disease : an orphan disease with many faces" 9 : 110-, 2014

42 Stone JH., "IgG4-related disease" 366 : 539-551, 2012

43 Mahajan VS., "IgG4-related disease" 9 : 315-347, 2014

44 Kamisawa T., "IgG4-related disease" 385 : 1460-1471, 2015

45 Yao Q., "IgG4-related Mikulicz's disease is a multiorgan lymphoproliferative disease distinct from Sjögren's syndrome : a Caucasian patient and literature review" 31 : 289-294, 2013

46 Geyer JT., "IgG4-associated sialadenitis" 23 : 95-101, 2011

47 Bindon CI., "Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q" 168 : 127-142, 1988

48 Grimm KE., "Histopathological findings in 29 lymph node biopsies with increased IgG4 plasma cells" 25 : 480-491, 2012

49 Hamano H., "High serum IgG4 concentrations in patients with sclerosing pancreatitis" 344 : 732-738, 2001

50 Nouri-Aria KT., "Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity" 172 : 3252-3259, 2004

51 Wynn TA., "Fibrotic disease and the T(H)1/T(H)2 paradigm" 4 : 583-594, 2004

52 Deshpande V., "Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease" 65 : 725-728, 2012

53 Khoury P., "Eosinophils in vasculitis : characteristics and roles in pathogenesis" 10 : 474-483, 2014

54 Padigel UM., "Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice" 196 : 1844-1851, 2007

55 Deshpande V., "Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease" 35 : 701-706, 2011

56 Green MG., "Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris" 144 : 1621-1624, 2008

57 Sah RP., "Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis" 139 : 140-148, 2010

58 Kim JH., "Diagnostic strategy for differentiating autoimmune pancreatitis from pancreatic cancer" 41 : 639-647, 2012

59 Detlefsen S., "Deposition of complement C3c, immunoglobulin(Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis" 57 : 825-835, 2010

60 Sellam J., "Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus" 66 : 790-797, 2007

61 Deshpande V., "Consensus statement on the pathology of IgG4-related disease" 25 : 1181-1192, 2012

62 Umehara H., "Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD), 2011" 22 : 21-30, 2012

63 Saeki T., "Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis" 78 : 1016-1023, 2010

64 Furukawa S., "Clinical relevance of Küttner tumour and IgG4-related dacryoadenitis and sialoadenitis" 21 : 257-262, 2015

65 Watanabe T., "Clinical features of a new disease concept, IgG4-related thyroiditis" 42 : 325-330, 2013

66 Yamaguchi Y., "Characteristic tubulointerstitial nephritis in IgG4-related disease" 43 : 536-549, 2012

67 Della-Torre E, "B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease" 2014

68 Lin W., "B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome : the similarities and differences" 16 : R118-, 2014

69 Kamisawa T., "Autoimmune pancreatitis and IgG4-related sclerosing disease" 7 : 401-409, 2010

70 Sato Y., "Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes" 25 : 956-967, 2012

71 Okazaki K., "Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan" 2012 : 357071-, 2012

72 Holland M., "Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis : a possible pathogenic role for the IgG4 subclass" 138 : 183-192, 2004

73 Gordon S., "Alternative activation of macrophages" 3 : 23-35, 2003

74 Fellrath JM., "Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides : results of a phase I trial" 111 : 854-861, 2003

75 Inokuchi G., "A suspected case of coronary periarteritis due to IgG4-related disease as a cause of ischemic heart disease" 10 : 103-108, 2014

76 Himi T., "A novel concept of Mikulicz's disease as IgG4-related disease" 39 : 9-17, 2012

77 Kamisawa T., "A new clinicopathological entity of IgG4-related autoimmune disease" 38 : 982-984, 2003

78 Kasashima S., "A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta" 52 : 1587-1595, 2010

79 Khosroshahi A., "A clinical overview of IgG4-related systemic disease" 23 : 57-66, 2011

80 Ohshima K., "A case of IgG4-related dacryoadenitis that regressed without systemic steroid administration" 53 : 53-56, 2013